David R. Byrd

26.2k total citations · 5 hit papers
117 papers, 16.0k citations indexed

About

David R. Byrd is a scholar working on Oncology, Surgery and Pathology and Forensic Medicine. According to data from OpenAlex, David R. Byrd has authored 117 papers receiving a total of 16.0k indexed citations (citations by other indexed papers that have themselves been cited), including 47 papers in Oncology, 22 papers in Surgery and 20 papers in Pathology and Forensic Medicine. Recurrent topics in David R. Byrd's work include Pancreatic and Hepatic Oncology Research (13 papers), Breast Cancer Treatment Studies (13 papers) and Polyomavirus and related diseases (13 papers). David R. Byrd is often cited by papers focused on Pancreatic and Hepatic Oncology Research (13 papers), Breast Cancer Treatment Studies (13 papers) and Polyomavirus and related diseases (13 papers). David R. Byrd collaborates with scholars based in United States, United Kingdom and Canada. David R. Byrd's co-authors include Carolyn C. Compton, Donna M. Gress, Robert K. Brookland, Mahul B. Amin, Laura Meyer, Stephen B. Edge, David P. Winchester, Frederick L. Greene, Jeffrey E. Gershenwald and Merrick I. Ross and has published in prestigious journals such as New England Journal of Medicine, The Journal of Experimental Medicine and Journal of Clinical Oncology.

In The Last Decade

David R. Byrd

112 papers receiving 15.7k citations

Hit Papers

The Eighth Edition AJCC Cancer... 2001 2026 2009 2017 2017 2009 2001 2010 2020 1000 2.0k 3.0k 4.0k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. The Eighth Edition AJCC Cancer Staging Manual: Continuing to build a bridge from a population‐based to a more “personalized” approach to cancer staging
    2017 4.4k citations Mahul B. Amin, Frederick L. Greene et al. CA A Cancer Journal for Clinicians profile →
  2. Final Version of 2009 AJCC Melanoma Staging and Classification
    2009 3.3k citations Charles M. Balch, Jeffrey E. Gershenwald et al. Journal of Clinical Oncology profile →
  3. Prognostic Factors Analysis of 17,600 Melanoma Patients: Validation of the American Joint Committee on Cancer Melanoma Staging System
    2001 1.8k citations Charles M. Balch, Jeffrey E. Gershenwald et al. Journal of Clinical Oncology profile →
  4. Pathologic nodal evaluation improves prognostic accuracy in Merkel cell carcinoma: Analysis of 5823 cases as the basis of the first consensus staging system
    2010 383 citations Bianca D. Lemos, Barry E. Storer et al. profile →
  5. Managing Cancer Care During the COVID-19 Pandemic: Agility and Collaboration Toward a Common Goal
    2020 367 citations David R. Byrd et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David R. Byrd United States 44 10.4k 3.5k 3.1k 2.6k 2.4k 117 16.0k
Gerardo Botti Italy 60 6.7k 0.6× 5.2k 1.5× 2.0k 0.6× 3.4k 1.3× 1.5k 0.6× 541 14.9k
Katherine S. Panageas United States 77 9.6k 0.9× 4.6k 1.3× 2.0k 0.6× 2.0k 0.8× 1.8k 0.7× 322 19.5k
Philip S. Rosenberg United States 66 5.9k 0.6× 3.8k 1.1× 3.3k 1.1× 2.5k 0.9× 3.3k 1.4× 245 18.7k
Kelly M. McMasters United States 69 15.0k 1.5× 6.3k 1.8× 4.3k 1.4× 4.5k 1.7× 5.1k 2.1× 434 23.5k
Víctor G. Prieto United States 65 8.8k 0.8× 4.8k 1.3× 1.7k 0.5× 1.5k 0.6× 3.3k 1.4× 556 16.0k
John L. Marshall United States 66 7.6k 0.7× 3.6k 1.0× 4.9k 1.6× 1.9k 0.7× 980 0.4× 431 16.4k
Michael Friedländer Australia 73 15.7k 1.5× 7.5k 2.1× 3.2k 1.1× 4.6k 1.7× 1.2k 0.5× 493 27.5k
Jeffrey N. Myers United States 69 6.5k 0.6× 6.5k 1.8× 2.9k 1.0× 2.7k 1.0× 1.1k 0.4× 359 15.7k
Alfred E. Chang United States 67 11.3k 1.1× 4.2k 1.2× 2.5k 0.8× 2.0k 0.8× 1.4k 0.6× 295 20.9k
Ian A. Cree United Kingdom 48 4.9k 0.5× 4.7k 1.3× 2.0k 0.7× 3.0k 1.2× 2.8k 1.2× 230 17.6k

Countries citing papers authored by David R. Byrd

Since Specialization
Citations

This map shows the geographic impact of David R. Byrd's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David R. Byrd with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David R. Byrd more than expected).

Fields of papers citing papers by David R. Byrd

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David R. Byrd. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David R. Byrd. The network helps show where David R. Byrd may publish in the future.

Co-authorship network of co-authors of David R. Byrd

This figure shows the co-authorship network connecting the top 25 collaborators of David R. Byrd. A scholar is included among the top collaborators of David R. Byrd based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David R. Byrd. David R. Byrd is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Voillet, Valentin, Trisha R. Berger, Kelly M. McKenna, et al.. (2022). An In Vivo Model of Human Macrophages in Metastatic Melanoma. The Journal of Immunology. 209(3). 606–620. 7 indexed citations
3.
Bhatia, Shailender, Natalie Miller, Rima M. Kulikauskas, et al.. (2019). Intratumoral Delivery of Plasmid IL12 Via Electroporation Leads to Regression of Injected and Noninjected Tumors in Merkel Cell Carcinoma. Clinical Cancer Research. 26(3). 598–607. 70 indexed citations
4.
Bhatia, Shailender, Natalie J. Miller, Hailing Lu, et al.. (2018). Intratumoral G100, a TLR4 Agonist, Induces Antitumor Immune Responses and Tumor Regression in Patients with Merkel Cell Carcinoma. Clinical Cancer Research. 25(4). 1185–1195. 103 indexed citations
5.
O’Sullivan, Brian, James D. Brierley, David R. Byrd, et al.. (2017). The TNM classification of malignant tumours—towards common understanding and reasonable expectations. The Lancet Oncology. 18(7). 849–851. 187 indexed citations
6.
Amin, Mahul B., Frederick L. Greene, Stephen B. Edge, et al.. (2017). The Eighth Edition AJCC Cancer Staging Manual: Continuing to build a bridge from a population‐based to a more “personalized” approach to cancer staging. CA A Cancer Journal for Clinicians. 67(2). 93–99. 4353 indexed citations breakdown →
7.
Boughey, Judy C., Karla V. Ballman, Linda McCall, et al.. (2017). Tumor Biology and Response to Chemotherapy Impact Breast Cancer-specific Survival in Node-positive Breast Cancer Patients Treated With Neoadjuvant Chemotherapy. Annals of Surgery. 266(4). 667–676. 56 indexed citations
8.
Byrd, David R., et al.. (2016). The Role of Dissonance and Harmony in one L2 Learner’s Identity Development during a Language Camp Experience Abroad. DergiPark (Istanbul University). 1 indexed citations
9.
Byrd, David R.. (2016). Putting the Writing Process into Action in the L2 Classroom: Pre-writing Techniques that Work. DergiPark (Istanbul University). 9 indexed citations
10.
O’Malley, Ryan B., et al.. (2016). Why Thyroid Surgeons Are Frustrated with Radiologists: Lessons Learned from Pre- and Postoperative US. Radiographics. 36(7). 2141–2153. 35 indexed citations
11.
Bhatia, Shailender, Barry E. Storer, Jayasri G. Iyer, et al.. (2016). Adjuvant Radiation Therapy and Chemotherapy in Merkel Cell Carcinoma: Survival Analyses of 6908 Cases From the National Cancer Data Base. JNCI Journal of the National Cancer Institute. 108(9). djw042–djw042. 164 indexed citations
12.
Byrd, David R.. (2012). Conducting Successful Home Visits in Multicultural Communities. 6(1). 43–54. 8 indexed citations
13.
Thompson, John F., Seng-Jaw Soong, Charles M. Balch, et al.. (2011). Prognostic Significance of Mitotic Rate in Localized Primary Cutaneous Melanoma: An Analysis of Patients in the Multi-Institutional American Joint Committee on Cancer Melanoma Staging Database. Journal of Clinical Oncology. 29(16). 2199–2205. 250 indexed citations
14.
Paulson, Kelly G., Jayasri G. Iyer, Andrew Tegeder, et al.. (2011). Transcriptome-Wide Studies of Merkel Cell Carcinoma and Validation of Intratumoral CD8+ Lymphocyte Invasion As an Independent Predictor of Survival. Journal of Clinical Oncology. 29(12). 1539–1546. 224 indexed citations
15.
Iyer, Jayasri G., Olga K. Afanasiev, Christopher L. McClurkan, et al.. (2011). Merkel Cell Polyomavirus-Specific CD8+ and CD4+ T-cell Responses Identified in Merkel Cell Carcinomas and Blood. Clinical Cancer Research. 17(21). 6671–6680. 115 indexed citations
16.
Balch, Charles M., Jeffrey E. Gershenwald, Seng-Jaw Soong, et al.. (2010). Multivariate Analysis of Prognostic Factors Among 2,313 Patients With Stage III Melanoma: Comparison of Nodal Micrometastases Versus Macrometastases. Journal of Clinical Oncology. 28(14). 2452–2459. 287 indexed citations
17.
Balch, Charles M., Jeffrey E. Gershenwald, Seng-Jaw Soong, et al.. (2009). Final Version of 2009 AJCC Melanoma Staging and Classification. Journal of Clinical Oncology. 27(36). 6199–6206. 3342 indexed citations breakdown →
18.
Byrd, David R. & Iftikhar Ahmed. (1997). Photosensitive Lichenoid Reaction to Torsemide—a Loop Diuretic. Mayo Clinic Proceedings. 72(10). 930–931. 2 indexed citations
19.
Curley, Steven A., David R. Byrd, Robert A. Newman, et al.. (1991). Hepatic arterial infusion chemotherapy with complete hepatic venous isolation and extracorporeal chemofiltration. Anti-Cancer Drugs. 2(2). 175–184. 17 indexed citations
20.
Evans, Douglas B., David R. Byrd, & Paul F. Mansfield. (1991). Preoperative Chemoradiotherapy for Adenocarcinoma of the Pancreas. American Journal of Clinical Oncology. 14(4). 359–359. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Gerardo Botti Breakdown of academic impact, for papers by Katherine S. Panageas Breakdown of academic impact, for papers by Philip S. Rosenberg Breakdown of academic impact, for papers by Kelly M. McMasters Breakdown of academic impact, for papers by Víctor G. Prieto Breakdown of academic impact, for papers by John L. Marshall Breakdown of academic impact, for papers by Michael Friedländer Breakdown of academic impact, for papers by Jeffrey N. Myers Breakdown of academic impact, for papers by Alfred E. Chang Breakdown of academic impact, for papers by Ian A. Cree
Rankless by CCL
2026